265 related articles for article (PubMed ID: 21325652)
21. Interaction of APOE, cerebral blood flow, and cortical thickness in the entorhinal cortex predicts memory decline.
Hays CC; Zlatar ZZ; Meloy MJ; Bondi MW; Gilbert PE; Liu T; Helm JL; Wierenga CE
Brain Imaging Behav; 2020 Apr; 14(2):369-382. PubMed ID: 32048144
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal connectivity and memory decline in cognitively intact APOE ε4 carriers.
Baxter LC; Limback-Stokin M; Patten KJ; Arreola AC; Locke DEC; Hu L; Zhou Y; Caselli RJ
Alzheimers Dement; 2023 Sep; 19(9):3806-3814. PubMed ID: 36906845
[TBL] [Abstract][Full Text] [Related]
23. Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use.
Jacobs EG; Kroenke C; Lin J; Epel ES; Kenna HA; Blackburn EH; Rasgon NL
PLoS One; 2013; 8(2):e54713. PubMed ID: 23418430
[TBL] [Abstract][Full Text] [Related]
24. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
Xu Y; Sun Z; Jonaitis E; Deming Y; Lu Q; Johnson SC; Engelman CD
Alzheimers Dement; 2024 Feb; 20(2):1063-1075. PubMed ID: 37858606
[TBL] [Abstract][Full Text] [Related]
26. Education, APOE ε4, and Cognition in Individuals with Subjective Cognitive Decline with Worry in the SILCODE Study.
Chen G; Lin L; Yang K; Han Y
Curr Alzheimer Res; 2021; 18(6):492-498. PubMed ID: 34598665
[TBL] [Abstract][Full Text] [Related]
27. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
28.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal change in working memory as a function of APOE genotype in midlife and old age.
Greenwood PM; Espeseth T; Lin MK; Reinvang I; Parasuraman R
Scand J Psychol; 2014 Jun; 55(3):268-77. PubMed ID: 24853824
[TBL] [Abstract][Full Text] [Related]
30. Age-related differences in white matter integrity and cognitive function are related to APOE status.
Ryan L; Walther K; Bendlin BB; Lue LF; Walker DG; Glisky EL
Neuroimage; 2011 Jan; 54(2):1565-77. PubMed ID: 20804847
[TBL] [Abstract][Full Text] [Related]
31.
Harker SA; Al-Hassan L; Huentelman MJ; Braden BB; Lewis CR
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958971
[TBL] [Abstract][Full Text] [Related]
32. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
[TBL] [Abstract][Full Text] [Related]
33. Association of
GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
[TBL] [Abstract][Full Text] [Related]
34. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes.
Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD;
Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545
[TBL] [Abstract][Full Text] [Related]
35. Hypertension moderates the effect of APOE on 21-year cognitive trajectories.
de Frias CM; Schaie KW; Willis SL
Psychol Aging; 2014 Jun; 29(2):431-9. PubMed ID: 24956008
[TBL] [Abstract][Full Text] [Related]
36. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
37. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of the APOE genotype on brain function across the lifespan.
Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
[TBL] [Abstract][Full Text] [Related]
39. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
40. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]